tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

FDC Limited Gains U.S. FDA Approval for Ophthalmic Solution

Story Highlights
FDC Limited Gains U.S. FDA Approval for Ophthalmic Solution

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

FDC Ltd. ( (IN:FDC) ) has shared an update.

FDC Limited has announced that it has received ANDA approval from the U.S. FDA for its Pilocarpine Hydrochloride Ophthalmic Solution USP in concentrations of 1%, 2%, and 4%. This approval allows FDC Limited to market this ophthalmic solution in the United States, potentially strengthening its position in the pharmaceutical industry and expanding its product offerings in the ophthalmic segment.

More about FDC Ltd.

Average Trading Volume: 11,058

Technical Sentiment Signal: Hold

Current Market Cap: 74.34B INR

See more insights into FDC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1